Mechanisms of PARP Inhibition: A Mode of Targeted Cancer Treatment

PARP Inhibitors simplifiedПодробнее

The Role of PARP Inhibitors in Advanced Prostate Cancer (2023)Подробнее

How PARP inhibitors (PARPi) workПодробнее

UROwebinar: PARP inhibitors in prostate cancer Part 2Подробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Role of PARP Inhibitors in Prostate CancerПодробнее

Ovarian Cancer Symposium 2021: Session 2 Immunotherapy and Targeted TherapyПодробнее

Breast Cancer and Autophagy | Albany State UniversityПодробнее

Medical Update: HER2-Positive Metastatic Breast CancerПодробнее

An Overview of PARP Inhibitors in Ovarian CancerПодробнее

ACTG Dinner Symposium Highlights | Beyond BRCA testing – does HRD matter? | Prof Michael FriedlanderПодробнее

PARP Inhibitors in 2020: Where Are We Now, and Where Are We Going | Webinar | Ambry GeneticsПодробнее

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChatПодробнее

Discovering PARP inhibitor resistance mechanisms using genome-wide and focused CRISPR screensПодробнее

PARP Inhibitor Therapy for Ovarian Cancer: Practical Prescribing and Medication ManagementПодробнее

The Role of Targeting DNA Repair with PARPПодробнее

Mechanistic Activity and Development History of CDK 4/6 InhibitorsПодробнее

Testing for BRCA Germline Mutations in the Clinic and the Mechanism of Action of PARP InhibitorsПодробнее

PARP Inhibitors in Ovarian Cancer Treatment | Webinar | Ambry GeneticsПодробнее